1 July 2019 in Archives of Gynecology and Obstetrics
1 January 2002 in European Journal of Obstetrics & Gynecology and Reproductive Biology
1 October 2015 in European Journal of Obstetrics & Gynecology and Reproductive Biology
2 August 2021 in Gynecology Obstetrics & Reproductive Medicine
Objective: Maspin is one of the members of serin protease inhibitor superfamily, and acts as a tumor suppressor protein. Here we report maspin expression in placental tissues of preeclampsia or intrauterine growth retardation pregnancies.Study Design: Maspin expression level was analyzed by semi-quantitative RT-PCR method. For this purpose, placental tissue samples were obtained from pregnancies 13 with intrauterine growth retardation, and 6 with preeclampsia, and also 12 tissues from women without preeclampsia or intrauterine growth retardation history were included as controls. Results: Maspin expression was found to be 11-fold higher in placentas from preeclampsia patients than placentas from intrauterine growth retardation patients (p=0.036). However, there was no difference between preeclampsia and control groups (p=0.76), and intrauterine growth retardation and control groups (p=0.849).Conclusion: As far as we know this is the first study reporting expression level of maspin in placental tissues of pregnancies with intrauterine growth retardation. These findings support that molecular pathology between preeclampsia and IUGR might be different at the molecular level and maspin levels in the placenta may be used to differentiate preeclampsia from IUGR.
13 July 2025 in Journal of Midwifery and Health Sciences
Objective: The aim of this descriptive study was to determine the level of surgical fear and related factors in patients undergoing total knee arthroplasty. Methods: The study sample consisted of 181 patients undergoing total knee arthroplasty in a training and research hospital in Izmir. The data were collected between April 1 and September 1, 2023 via the “Patient Identification Form” and the “Surgical Fear Scale”. Descriptive statistics, Mann Whitney U test, Kruskal Wallis test and Spearman correlation analysis were used to evaluate the data. Results: The mean score on the Surgical Fear Scale was found to be 28.35 ± 16.89 (out of 80 points), indicating that the level of fear experienced by patients scheduled for total knee arthroplasty was relatively low. The mean scores for the short-term and long-term fear subscale of the Surgical Fear Scale (16.10 ± 9.91 and 12.24 ± 9.44 out of 40, respectively) also indicated that the short-term and long-term fear levels were low. The factors associated with the level of surgical fear were found to be previous knee surgery history and type of anesthesia (p: .001). Conclusion: The study findings showed that patients undergoing total knee arthroplasty experienced low levels of fear and that previous knee surgery experience and type of anesthesia were associated with this fear. surgical fear levels.